Skip to main content

2-Day Seminar on Nasal Drug Delivery (London, United Kingdom - April 11-12, 2019) - ResearchAndMarkets.com

The "Nasal Drug Delivery" conference has been added to ResearchAndMarkets.com's offering.

This conference gives a comprehensive review within the field of nasal drug delivery while reviewing interesting new data and innovative technologies

What makes nasal delivery systems more challenging than solid dosage forms? How safe is nasal drug delivery? Are there such things as safe excipients? How does all this fit within the regulatory environment in Europe and the USA? How difficult is it to bring all these products to market?

This seminar seeks to explore these and other questions within the field of nasal drug delivery while reviewing interesting new data, innovative technologies and the very latest scientific developments. Leading authorities in nasal drug delivery will cover relevant aspects of nasal physiology, anatomy, absorption of a variety of drugs in various phases of drug development, and new drugs entering the market. In addition, nasal delivery to the sinuses will be discussed and the programme will include interesting case histories.

The seminar will offer an excellent networking opportunity to build business relationships and discuss all these issues with an unrivalled panel of experts in this field of drug delivery.

Three reasons to attend:

1. Gain an update on the very latest scientific developments and technology advances in this field

2. Hear from an unrivalled panel of expert speakers

3. An excellent networking opportunity to build business relationships

Who Should Attend?

  • Managing directors
  • Medical directors
  • Heads of regulatory affairs
  • Quality assurance managers
  • Senior executives in research and development
  • Registration associates
  • Marketing managers
  • All departments that are involved in nasal drug delivery, or who wish to understand the potential of this alternative therapeutic route

Those already involved in nasal drug delivery will benefit from updating their knowledge and sharing experiences with some of the leading practitioners in this field. If you are involved in nasal drug delivery or are just considering the potential, this seminar is an excellent route to understanding all aspects from the basic physiology through to launching a successful product.

Agenda

Nasal drugs to treat nasal disorders: a comprehensive review

  • Anatomy and physiology
  • Nasal disorders
  • Treatment options and future prospects to treat allergic and non-allergic rhinitis
  • CRS with and without nasal polyps
  • Professor Valerie Lund

Nasal drug delivery challenges

  • Discuss ideal attributes of a nasal spray formulation
  • Present strategies to optimise deposition
  • Highlight excipients to facilitate absorption
  • Present technology for delivery and formulation characterisation
  • Dr Julie Suman

Nasal formulation of drugs

  • Formulation aspects of liquid systems
  • Carrier-based and matrix dry powder formulations for nasal delivery
  • (Nano)particulate drug carriers for nasal administration
  • Interplay of therapeutic targets and nasal deposition
  • Dr Regina Scherliess

Developing next generation powder nasal delivery using POD technology

  • Device development efforts
  • Formulation development efforts
  • Unique challenges to powder delivery
  • Christopher Fuller

Rethinking nasal packaging environment

  • Using integrated three-phase activ-polymer to control moisture ingress
  • Extend shelf life
  • Improve performance
  • Lee Lucas

Key insights for a successful device development to achieve nasal bioequivalence requirements

  • Design and testing techniques for nasal spray devices
  • In-Vitro BioEquivalence (IVBE) requirements and region-specific regulatory strategies
  • Statistical tools and new alternative approach applied to nasal sprays
  • Key success factors for nasal spray development projects
  • Pascale Farjas and Celine Petitcola

The unique challenges of nasal drug delivery to treat chronic rhinosinusitis (CRS); considerations before and after sinus surgery

  • Medical therapy in CRS - goals and challenges
  • Endoscopic sinus surgery - implications for drug deposition
  • Nasal delivery methods - advantages and limitations
  • Per Djupesland

Review of nasal drug delivery devices

  • Trends in nasal delivery systems
  • Advances in device technologies
  • Nasal spray characteristics
  • Dr Rene Bommer

Requirements concerning bioequivalence of nasal drug products from an authority's point of view

  • Bioequivalence of nasal products
  • The evaluation of the monograph for nasal products in the European Pharmacopoeia will be outlined
  • Dr Cornelia Nopitsch-Mai

Regulatory science associated with BE/TE for nasal products

  • Average BE versus population BE
  • End point right, outcome wrong: why?
  • Getting the sample size right
  • Lessons learned from inhaled aerosol products
  • Anders Fuglsang

US/FDA regulatory guidance on combination products

  • Origin and objective of the regulations
  • The regulation and guidance documents
  • Requirements and expectations of FDA
  • Andrew Wood

Qualification of new nasal drug delivery systems for existing drugs

  • Formulation analysis
  • System and compatibility
  • Stability testing
  • Performance testing
  • Production line and efficiency optimisation
  • Thomas Grinnan

Investigations regarding the developability of nasal metered dose inhalers

  • Findings
  • Opportunities Dr Jag Shur

What are chemisimilars and what's the problem?

  • Standardisation
  • EU guidance
  • FDA guidance
  • Assay sensitivity and the best models to test for similarity
  • Dr John Warren

Discussion session

Concluding remarks

Close of conference and refreshments

For more information about this conference visit https://www.researchandmarkets.com/research/k79ns8/2day_seminar_on?w=4

Contacts:

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Transdermal and Transmucosal Drug Delivery

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.